Indiana Biosciences Research Institute

04/12/2024

We're pleased to welcome Jonathan to the IBRI! He's a talented pharmacologist, who will be working with Pat Knerr and his team to translate high-impact basic research into early drug discovery projects.

04/10/2024

"The IBRI has an environment of individuals who are collaborative and interested in solving big health problems." Learn more from Assistant Investigator Jonathan Flak about how he's investigating novel neuro pathways that are relevant to diabetes.

04/08/2024

We'll be safely watching the total solar eclipse with our Indianapolis neighbors starting at 1:50 p.m. today, with totality falling between 3:06 and 3:09 p.m.! Be safe out there and enjoy!

04/05/2024

We're happy to welcome Matt to the IBRI team! Matt has more than 25 years of drug discovery experience and will be working in our medicinal chemistry group to help enhance its pharmaceutical lead generation capabilities.

03/27/2024

"One of the unique aspects of the IBRI is that we can run our labs like we're an academic institution, but we have the advantage of forming partnerships with other industries." Learn more from Michael Kalwat, assistant investigator, about how these collaborations are filling in pieces of the diabetes puzzle.

03/18/2024

We're pleased to welcome the newest member of our team - Kaitlyn - to the Kalwat Lab! Kaitlyn will help investigate the molecular mechanisms of regulated secretion using genetic and pharmacological tools.

03/13/2024

"My lab is interested in understanding the things that are happening early on in diabetes and how we can intervene to protect beta cells." Learn more from Assistant Investigator Andrew Templin, PhD, about how this work can help delay diabetes.

03/07/2024

We're happy to have Indiana University School of Medicine PhD Student Abigail join us for the next eight weeks as she works to complete her rotation in the .

02/21/2024

I am implementing a, "system that we can very rapidly with minimal cost discover high quality antibodies that can be used for molecular diagnostics. Learn more about our antibody discovery technologies from Staff Scientist Justin Layer.

02/21/2024

We are thrilled to welcome new IBRI member company - Teichos Laboratories! Teichos employs chemoenzymatic synthesis to access its platform to macromolecular biologics for diverse applications in immunotherapy and vaccine development.

02/07/2024

"My cross disciplinary expertise in biology, statistics and computer science makes it possible to design novel computational tools." Learn from Travis Johnson how we're using bioinformatics to accelerate neurodegenerative disease research.

02/06/2024

We're pleased to welcome new IBRI member company - Entomol. Entomol is the exclusive producer of the EPA-registered insect repellent Refined Oil of Nepeta cataria.

01/22/2024

As we continue to grow, we're thrilled to announce the arrival of our new human resources director! Amy will implement our career path framework, oversee talent acquisition and ensure the development and retention of a high-performing workforce.

01/15/2024

We're excited to welcome Pat to the IBRI team. He joins us from Novo Nordisk and will be focused on translating early research findings into innovative drug candidates.

01/15/2024

01/12/2024

This week we welcomed two interns to the bioinformatics team. Alex is working on his master's degree in bioinformatics at IUPUI. Mayowa recently graduated from IUPUI with a bachelor's degree in bioinformatics.

01/11/2024

We're so excited to welcome Susie to the IBRI team that we couldn't wait to get a better photo. Susie is joining to coordinate our members, manage the conference center and support lab operations.

01/11/2024

"I meet with people to find the next set of science we should be focusing on; that might be working with biotechs, government labs or even venture." Learn more about how we move science forward from Scientific Business Development VP Sharon Semones.